LOW DOSE CONTINUOUS THERAPY WITH DASATINIB SIGNIFICANTLY IMPACT ON SURVIVAL OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA (CML) RESISTANT OR INTOLERANT TO IMATINIB. RESULTS FROM A REAL LIFE-BASED ITALIAN MULTICENTER RETROSPECTIVE STUDY ON 114 UNSELECTED PATIENTS / G VISANI; M BRECCIA; A GOZZINI; G SPECCHIA; E MONTEFUSCO; E MORRA; M ANNUNZIATA; L LUCIANO; A CAMERA; F CAVAZZINI; F STAGNO; DI RAIMONDO F; P PREGNO; V SANTINI; P PICCALUGA; M PACILLI; E PUNGOLINO; E USALA; E ANGELUCCI; A CUNEO; F FERRARA; M CRUGNOLA; G BINOTTO; E MAINO; R LATAGLIATA; G NICOLINI; S BARULLI; F LOSCOCCO; G ALIMENA; A ISIDORI. - 95 (supp. 2)(2010), pp. 345-345.
Titolo: | LOW DOSE CONTINUOUS THERAPY WITH DASATINIB SIGNIFICANTLY IMPACT ON SURVIVAL OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA (CML) RESISTANT OR INTOLERANT TO IMATINIB. RESULTS FROM A REAL LIFE-BASED ITALIAN MULTICENTER RETROSPECTIVE STUDY ON 114 UNSELECTED PATIENTS |
Autori interni: | |
Data di pubblicazione: | 2010 |
Handle: | http://hdl.handle.net/20.500.11769/74109 |
Appare nelle tipologie: | 4.1 Contributo in Atti di convegno |